Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04101500
Other study ID # 2018S446-1
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date April 1, 2019
Est. completion date December 30, 2024

Study information

Verified date September 2019
Source Wuhan Union Hospital, China
Contact Yang Jin
Phone 027-85726114
Email whuhjy@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an important event in the management of chronic obstructive pulmonary disease. Compound sodium chlolate and aminophylline tablets are one of the most widely used drugs for the treatment of bronchial asthma and chronic bronchitis.


Description:

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an unignorable event in the management of chronic obstructive pulmonary disease. It is crucial to seek for effective management strategy. Compound sodium chlolate and aminophylline tablets are one of the most widely used drugs for the treatment of bronchial asthma and chronic bronchitis. Compared with the local bronchodilator recommended by the guidelines, it has the advantages of convenient use and good patient compliance. For the purpose of optimize the management of acute exacerbation of chronic obstructive pulmonary disease and provide more convenient options, we compared the efficacy of combined compound sodium chlolate and aminophylline tablets with nebulized ipratropium bromide inhalation plus systemic glucocorticoids in the treatment of chronic obstructive pulmonary disease ranging from moderate degree to severe degree. We hope this research would benefit patients with chronic obstructive pulmonary, especially those in the grassroots.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 30, 2024
Est. primary completion date December 30, 2020
Accepts healthy volunteers No
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- (1)All subjects must sign an informed consent form before participating in the clinical trial.

(2)Clinical diagnosis of AECOPD. (3)Must be able to swallow tablets.

Exclusion Criteria:

- (1)Heart disease. (2)Insulin dependent diabetes. (3)Tumor disease. (4)Thyroid disease. (5)Infectious diseases such as hepatitis B, active tuberculosis, etc. (6)Active peptic ulcer. (7)Allergic to related treatments. (8)Participate in other clinical trials within three months. (9)Women who are breast-feeding, pregnant or preparing for pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Compound Ipratropium Bromide Solution(C1) for Inhalation
The patient's condition and basic condition were the same in the experimental group and the control group.
Compound Sodium Chlolate and Aminophylline Tablets(C2)
Applied only to the experimental group.
Placebo Tablets
Applied only to the control group.

Locations

Country Name City State
China Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Wuhan Union Hospital, China

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary COPD assessment test(CAT) score Observe the changes in the symptoms of dyspnea each time.The CAT score consists of eight items, each of which has options of 0, 1, 2, 3, 4, and 5. The lower the total score plus the score for the eight items, the lighter the symptoms of COPD.The first item, whether there is cough; the second item, sputum condition; the third item, whether there is chest tightness; the fourth item, when climbing a hill or climbing a layer of stairs, is there any breathlessness;the fifth item, whether chronic obstructive pulmonary disease affects housework; the sixth item, whether it affects going out; the seventh item, sleep situation; the eighth item, whether the energy is sufficient. The above test was given to the experimental group and the control group on the first, fourth, and eighth days after the treatment.
Primary Potential of Hydrogen(PH),Partial pressure of oxygen(PO2),Partial pressure of carbon dioxide(PCO2) Arterial blood gas values were monitored, the values measured at each examination were recorded, and changes between each time were observed. The above test was given to the experimental group and the control group on the first, fourth, and eighth days after the treatment.
Secondary Forced Expiratory Volume in the first second (FEV1)/Forced Vital Capacity(FVC) Observe the changes in lung function each time. The above test was given to the test group and the control group on the first and eighth days after the treatment.
See also
  Status Clinical Trial Phase
Completed NCT04044625 - Effects of High-intensity Noninvasive Positive Pressure Ventilation in AECOPD N/A
Active, not recruiting NCT03751670 - Pulmonary Rehabilitation During Acute Exacerbations of Chronic Obstructive Pulmonary Disease: a Mixed-methods Approach N/A
Completed NCT03083418 - The Effect of EDP on Diaphragmatic Function and Neural Respiratory Drive in Patient With AECOPD N/A
Recruiting NCT04183530 - The Individualized Accurate Diagnosis and Treatment of Chronic Objective Pulmonary Disease(COPD) Patients Based on Multidimensional Data
Enrolling by invitation NCT06189586 - Comparison of Aerosol Inhalation and Intravenous Glucocorticoid in the Treatment of Severe AECOPD N/A
Recruiting NCT06134063 - A Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Not yet recruiting NCT06114667 - Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis N/A
Not yet recruiting NCT05222711 - The Use of a Monitoring Device by General Practitioners During Out-of-hours Care N/A
Recruiting NCT05480566 - Functional Strength Training and Neuromuscular Electrical Stimulation in Severe Acute Exacerbations of COPD N/A
Terminated NCT02985918 - High-Intensity vs Low-Intensity NPPV in Patients With an AECOPD: The HAPPEN Trial N/A
Recruiting NCT06175065 - Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT04316312 - The Inspiratory Muscle Activation Pattern and Training Efficacy in Patients With Chronic Obstructive Pulmonary Disease After Acute Exacerbation N/A
Recruiting NCT04259736 - Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPD
Completed NCT03633838 - Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China
Completed NCT02051166 - Clinical Practice of AECOPD Management in China N/A
Recruiting NCT04212182 - The Physiological Effect of High Flow Oxygen Therapy N/A
Not yet recruiting NCT06455670 - Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD N/A